WO2023221560A1 - 一种用于治疗青光眼的消融电极及消融主机 - Google Patents
一种用于治疗青光眼的消融电极及消融主机 Download PDFInfo
- Publication number
- WO2023221560A1 WO2023221560A1 PCT/CN2023/074464 CN2023074464W WO2023221560A1 WO 2023221560 A1 WO2023221560 A1 WO 2023221560A1 CN 2023074464 W CN2023074464 W CN 2023074464W WO 2023221560 A1 WO2023221560 A1 WO 2023221560A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- electrode
- ablation
- treating glaucoma
- handle
- ablation electrode
- Prior art date
Links
- 238000002679 ablation Methods 0.000 title claims abstract description 154
- 208000010412 Glaucoma Diseases 0.000 title claims abstract description 37
- 210000004240 ciliary body Anatomy 0.000 claims abstract description 33
- 210000001742 aqueous humor Anatomy 0.000 claims description 15
- 210000003128 head Anatomy 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000007674 radiofrequency ablation Methods 0.000 abstract description 4
- 210000003786 sclera Anatomy 0.000 abstract description 4
- 238000010586 diagram Methods 0.000 description 6
- 230000004410 intraocular pressure Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000035515 penetration Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 4
- 229910052721 tungsten Inorganic materials 0.000 description 4
- 239000010937 tungsten Substances 0.000 description 4
- 206010016760 Flat anterior chamber of eye Diseases 0.000 description 3
- 210000002159 anterior chamber Anatomy 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 210000001328 optic nerve Anatomy 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000542420 Sphyrna tudes Species 0.000 description 1
- 206010047555 Visual field defect Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000004493 normal intraocular pressure Effects 0.000 description 1
- 210000003733 optic disk Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
Definitions
- the present invention relates to the technical field of medical equipment, and in particular to an ablation electrode and an ablation host for treating glaucoma.
- Glaucoma is a group of diseases characterized by optic papilla atrophy and depression, visual field defects and vision loss. Pathological increase in intraocular pressure and insufficient blood supply to the optic nerve are the primary risk factors for its onset. The tolerance of the optic nerve to pressure damage Sex is also associated with the onset and progression of glaucoma. Obstacles in any part of the aqueous humor circulation pathway can lead to pathological changes caused by increased intraocular pressure, but some patients also present with normal intraocular pressure glaucoma.
- glaucoma can be treated through ablation.
- One of the methods is to destroy the aqueous humor tissue in the ciliary body through ablation, thereby reducing the production of aqueous humor in the ciliary body, reducing intraocular pressure, and achieving the purpose of treating glaucoma; Therefore, it is necessary to provide a specific ablation electrode and ablation host for this ablation method to meet the ablation requirements.
- the invention provides a coaxial ablation electrode, which solves the lack of an ablation electrode and an ablation host for ablating aqueous humor tissue in the ciliary body in the prior art.
- an ablation electrode for treating glaucoma including a central axis electrode located at the center of the ablation electrode, an insulating sleeve set around the periphery of the central axis electrode, and a sleeve set.
- the outer jacket electrode is on the periphery of the insulating sleeve; the ablation electrode is columnar as a whole, and the central axis electrode, the insulating sleeve, and the outer jacket electrode are coaxial. After the ablation electrode is energized, there is a gap between the central axis electrode and the outer jacket electrode.
- Ablation band the ablation band is used to act on the ciliary body to reduce the production of aqueous humor.
- the front end of the central axis electrode is processed into a first tapered tip.
- the front end of the insulating sleeve is processed into a second tapered tip, and the head of the second tapered tip receives the tail of the first tapered tip.
- the front end of the sheath electrode is processed into a third tapered tip, and the head of the third tapered tip receives the tail of the second tapered tip.
- the length of the outer jacket electrode is 3 mm to 50 mm, its inner diameter is 0.1 mm to 1.1 mm, and its outer diameter is 0.2 mm to 1.5 mm.
- the surface of the ablation electrode is provided with positioning scale marks.
- the present invention also provides an ablation host for treating glaucoma, which includes the above-mentioned ablation electrode and a handle connected to the ablation electrode.
- the tail of the handle is connected to a power-on connector through a tail wire.
- the handle includes a handle head that fixes the ablation electrode, and a handle tail that connects the tail wire and the electrical plug connector, and the handle head and the handle tail are connected by plugging. .
- a PCB circuit board for identifying the model of the ablation electrode is provided inside the handle.
- the present invention discloses an ablation electrode for treating glaucoma, which includes a central axis electrode located at the center of the ablation electrode, an insulating sleeve set around the periphery of the central axis electrode, and a jacket set around the periphery of the insulating sleeve. Electrode; the ablation electrode is cylindrical as a whole, and the central axis electrode, insulating sleeve, and jacket electrode are coaxial. After the ablation electrode is energized, an ablation zone is generated between the central axis electrode and the jacket electrode. The ablation zone is used to act on the ciliary body and reduce aqueous humor. of production.
- the present invention also provides an ablation host for treating glaucoma.
- the ablation host transmits ablation energy to the ablation electrode, and the ablation electrode penetrates into the ciliary body through the sclera.
- the ablation host outputs radiofrequency ablation energy and transmits it to the central axis electrode, and the energy current passes through the ciliary body.
- the body tissue is returned to the coat electrode.
- the ablation zone produced by the ablation electrode destroys the aqueous humor tissue of the ciliary body, thereby reducing the production of aqueous humor in the ciliary body, thereby achieving the purpose of reducing intraocular pressure and treating glaucoma.
- ablation of the ablation electrode can cause the ciliary body to shrink, increase the gap between the lens and the ciliary body, reduce ciliary body block, reduce the trans-lens pressure difference, and deepen the anterior chamber.
- Figure 1 is an overall schematic diagram of an ablation electrode for treating glaucoma according to the present invention
- Figure 2 is an exploded schematic diagram of an ablation electrode for treating glaucoma according to the present invention
- Figure 3 is a partial cross-sectional schematic view of an ablation electrode for treating glaucoma according to the present invention
- Figure 4 is a schematic diagram of the positioning scale of an ablation electrode used to treat glaucoma according to the present invention
- Figure 5 is a schematic diagram of a first embodiment of an ablation host for treating glaucoma according to the present invention.
- Figure 6 is a schematic diagram of a second embodiment of an ablation host for treating glaucoma according to the present invention.
- Figure 7 is a schematic diagram of a third embodiment of an ablation host for treating glaucoma according to the present invention.
- an ablation electrode 1 for treating glaucoma includes a central axis electrode 2 located at the center of the ablation electrode, an insulating sleeve 3 placed around the periphery of the central axis electrode 2, and The outer electrode 4 is arranged around the periphery of the insulating sleeve 3 .
- the ablation electrode 1 is in the shape of a column as a whole, and the central axis electrode 2, the insulating sleeve 3, and the outer electrode 4 are coaxial, that is, the central axes of the central axis electrode 2, the insulating sleeve 3, and the outer electrode 4 coincide with each other.
- the ablation electrode 1 in the present invention can easily enter the small eye space to ablate the ciliary body, producing a controllable micro ablation area; the ablation band 5 is concentrated between the central axis electrode 2 and the jacket electrode 3, and the ablation electrode 1
- the insertion position determines the ablation location, which can be on the surface of the tissue or a specific location inside the tissue.
- the ablation electrode 1 in the present invention is a single-needle ablation electrode, which is smaller in size than the existing ablation electrode, and during surgery, the single-needle ablation electrode causes less trauma than the existing multi-needle ablation electrode, and the operator More precise and convenient to use.
- the central axis electrode 2 has good biocompatibility and good electrical conductivity.
- the material of the central axis electrode 2 can be stainless steel, such as 2Cr13, 1Cr13, 1Cr18Ni9, SUS304(L), SUS316(L), SUS430, etc.; it can also be titanium alloy, such as TC4, etc.; it can also be pure titanium, tungsten steel, pure Tungsten, platinum, platinum-iridium alloy and other metal conductive materials.
- the central axis electrode 2 has a cylindrical shape as a whole, the length of the central axis electrode 2 is 3 mm to 50 mm, and the diameter is 0.1 mm to 1 mm.
- the front end of the central axis electrode 2 is processed into a first tapered tip 21 .
- the insulating sleeve 3 is in the form of a cylindrical sleeve as a whole, and the insulating sleeve 3 has good biocompatibility and insulation.
- the material of the insulating sleeve 3 can be Parylene/silica gel/PTFE/ABS/PI.
- the front end of the insulating sleeve 3 is processed into a second tapered tip 31, and the head of the second tapered tip 31 receives the tail of the first tapered tip 21, that is, the head of the second tapered tip 31 is formed from the first tapered tip 31.
- the tail of the tapered tip 21 smoothly transitions backward to the tail of the second tapered tip 31; its taper is consistent with the taper of the first tapered tip 21.
- the jacket electrode 4 has good biocompatibility and good electrical conductivity.
- the material of the jacket electrode 4 can be stainless steel, such as 2Cr13, 1Cr13, 1Cr18Ni9, SUS304(L), SUS316(L), SUS430, etc.; it can also be titanium alloy, such as TC4, etc.; it can also be pure titanium, tungsten steel, pure tungsten , platinum, platinum-iridium alloy and other metal conductive materials.
- the length of the jacket electrode 4 is 3 mm to 50 mm, its inner diameter is 0.1 mm to 1.1 mm, and its outer diameter is 0.2 mm to 1.5 mm.
- the front end of the outer jacket electrode 4 is processed into a third tapered tip 41, and the head of the third tapered tip 41 receives the tail part of the second tapered tip 31, that is, the head of the third tapered tip 41 is formed from the second tapered tip 41.
- the tail of 31 smoothly transitions backward to the tail of the third tapered tip 41; its taper is consistent with the taper of the second tapered tip 31, that is, consistent with the taper of the first tapered tip 21.
- positioning scale lines are provided on the surface of the ablation electrode 1 .
- the positioning scale line is made on the surface of the ablation electrode 1 and serves as a scale for the penetration depth of the ablation electrode 1, making it convenient for the doctor to control the penetration depth.
- the positioning scale line may be a closed loop line surrounding the ablation electrode 1, or it may be a half loop line or an arc line.
- the positioning scale mark can identify the distance from the display feature to the tip of the ablation electrode 1 through display features, and the display features can be colors, numbers, patterns, line widths, etc.
- the positioning scale marks include the first display scale mark 101 , the second display scale mark 102 and the third display scale mark 103 .
- it can also include more display scale marks and is not limited to these three display scale marks. .
- the length of the first display scale line 101 from the tip of the ablation electrode 1 is L1
- the length of the second display scale line 102 from the tip of the ablation electrode 1 is L2
- the length of the third display scale line 103 from the tip of the ablation electrode 1 is L3.
- the present invention also provides an ablation host for treating glaucoma, including the ablation electrode 1 as mentioned above, and a handle 6 connected to the ablation electrode 1.
- the ablation electrode 1 and the handle 6 can be detachably connected or fixed.
- the tail of the handle 9 is connected to the power plug connector 8 through the tail wire 7 .
- the use process of the ablation host is as follows: after the power plug 8 is connected to the power supply, the ablation host is turned on. The ablation host transmits the ablation energy to the ablation electrode 1 through the handle 6 . The ablation electrode is inserted from the outside of the eyeball and into the ciliary body through the sclera. The ablation host outputs radiofrequency ablation energy and transmits it to the central axis electrode 2, and the energy current returns to the outer jacket electrode 4 through the ciliary body tissue.
- the ablation effect is mainly concentrated on the tip of the central axis electrode 2, that is, the first tapered tip 21.
- the ablation zone 5 generated by the ablation electrode 1 destroys the aqueous humor tissue of the ciliary body, thereby reducing the generation of aqueous humor in the ciliary body, thereby achieving the purpose of reducing intraocular pressure and treating glaucoma.
- This method has the same effect on open-angle glaucoma and angle-closure glaucoma.
- Sterilization methods include: gas sterilization (ethylene oxide, formaldehyde, ozone), radiation sterilization (microwave, ultraviolet (UV), X-ray and ⁇ -ray, etc.).
- the handle 6 and the ablation electrode 1 are fixedly connected, and the handle 6, the tail wire, and the power-on connector 8 are an integrated structure.
- a PCB circuit board 9 for identifying the model of the ablation electrode 1 is provided inside the handle 6 .
- the PCB circuit board 9 is used to intelligently identify the model of the ablation electrode 1, and the ablation host automatically configures the model parameters of the corresponding ablation electrode 1. , assist doctors in operations and shorten operation time.
- the life span of the ablation electrode 1 can be intelligently identified to prevent expired ablation electrode 1 from being used in surgery.
- the handle 6 includes a handle head 61 fixedly connected to the ablation electrode 1, that is, one ablation electrode 1 corresponds to one handle head 61; the handle 6 also includes a handle head 61 connected to the ablation electrode 1.
- the tail wire and the handle tail 62 of the electrified connector, the handle head 61 and the handle tail 62 are connected by plugging, that is, the same handle tail 62 can be connected to different types of handle heads 61 by plugging. This makes it easy to replace different types of ablation electrodes 1 during surgery.
- the handle head 61 is provided with a PCB circuit board 9 for identifying the model of the ablation electrode 1.
- the PCB circuit board 9 can identify the model of the ablation electrode 1 in the handle head 61 and store the information to assist the doctor in the operation and shorten the operation time. .
- the life span of the ablation electrode 1 can be intelligently identified to prevent expired ablation electrode 1 from being used in surgery.
- an ablation electrode for treating glaucoma which includes a central axis electrode located at the center of the ablation electrode, an insulating sleeve set around the periphery of the central axis electrode, and an outer jacket electrode set around the periphery of the insulating sleeve; ablation
- the electrode is generally columnar, and the central axis electrode, insulating sleeve, and jacket electrode are coaxial. After the ablation electrode is energized, an ablation zone is generated between the central axis electrode and the jacket electrode. The ablation zone is used to act on the ciliary body and reduce the production of aqueous humor.
- the present invention also provides an ablation host for treating glaucoma.
- the ablation host transmits ablation energy to the ablation electrode, and the ablation electrode penetrates into the ciliary body through the sclera.
- the ablation host outputs radiofrequency ablation energy and transmits it to the central axis electrode, and the energy current passes through the ciliary body.
- the body tissue is returned to the coat electrode.
- the ablation zone produced by the ablation electrode destroys the aqueous humor tissue of the ciliary body, thereby reducing the production of aqueous humor in the ciliary body, thereby achieving the purpose of reducing intraocular pressure and treating glaucoma.
- ablation of the ablation electrode can cause the ciliary body to shrink, increase the gap between the lens and the ciliary body, reduce ciliary body block, reduce the trans-lens pressure difference, and deepen the anterior chamber.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Medical Informatics (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Vascular Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
一种用于治疗青光眼的消融电极(1),包括中心轴电极(2)、绝缘套(3)以及外套电极(4),中心轴电极(2)、绝缘套(3)、外套电极(4)同轴,消融电极(1)通电后,中心轴电极(2)与外套电极(4)之间产生消融带(5),一种用于治疗青光眼的消融主机,消融主机将消融能量传输至消融电极(1),消融电极(1)经巩膜刺入睫状体内,消融主机输出射频消融能量传递到中心轴电极(2),能量电流经睫状体组织返回外套电极(4)。
Description
本发明涉及医用器材技术领域,尤其涉及一种用于治疗青光眼的消融电极及消融主机。
青光眼(glaucoma)是一组以视***萎缩及凹陷、视野缺损及视力下降为共同特征的疾病,病理性眼压增高、视神经供血不足是其发病的原发危险因素,视神经对压力损害的耐受性也与青光眼的发生和发展有关。在房水循环途径中任何一环发生阻碍,均可导致眼压升高而引起的病理改变,但也有部分患者呈现正常眼压青光眼。
现有技术中,通过消融的方式能够治疗青光眼,其中一种方式是通过消融破坏睫状体内的房水组织,进而减少睫状体内的房水的生成,降低眼内压,达到治疗青光眼目的;所以针对该消融方式需要提供一种特定的消融电极及消融主机,以满足消融要求。
发明内容
本发明提供一种同轴消融电极,解决现有技术中缺乏一种对睫状体内的房水组织进行消融的消融电极及消融主机。
为解决上述技术问题,本发明采用的一个技术方案是提供一种用于治疗青光眼的消融电极,包括位于消融电极中心的中心轴电极、套设在所述中心轴电极***的绝缘套以及套设在所述绝缘套***的外套电极;消融电极整体呈柱状,所述中心轴电极、绝缘套、外套电极同轴,所述消融电极通电后,所述中心轴电极与所述外套电极之间产生消融带,所述消融带用于作用于睫状体,减少房水的产生。
优选的,所述中心轴电极的前端被加工为第一锥形尖端。
优选的,所述绝缘套的前端被加工为第二锥形尖端,所述第二锥形尖端的头部承接所述第一锥形尖端的尾部。
优选的,所述外套电极的前端被加工为第三锥形尖端,所述第三锥形尖端的头部承接所述第二锥形尖端的尾部。
优选的,所述中心轴电极的长度为3mm~50mm,直径为0.1mm~1mm。
优选的,所述外套电极的长度为3mm~50mm,其内径为0.1mm~1.1mm,外径为0.2mm~1.5mm。
优选的,所述消融电极的表面上设置有定位刻度线。
本发明还提供一种用于治疗青光眼的消融主机,包括上述所述的消融电极,以及连接所述消融电极的手柄,所述手柄的尾部通过尾线连接通电插接件。
优选的,所述手柄包括固定所述消融电极的手柄头部,以及连接所述尾线和通电插接件的手柄尾部,所述手柄头部与所述手柄尾部之间通过插接的方式连接。
优选的,所述手柄内部设置有用于识别所述消融电极型号的PCB电路板。
本发明的有益效果是:本发明公开了一种用于治疗青光眼的消融电极,包括位于消融电极中心的中心轴电极、套设在中心轴电极***的绝缘套以及套设在绝缘套***的外套电极;消融电极整体呈柱状,中心轴电极、绝缘套、外套电极同轴,消融电极通电后,中心轴电极与外套电极之间产生消融带,消融带用于作用于睫状体,减少房水的产生。本发明还提供一种用于治疗青光眼的消融主机,消融主机将消融能量传输至消融电极,消融电极经巩膜刺入睫状体内,消融主机输出射频消融能量传递到中心轴电极,能量电流经睫状体组织返回外套电极。消融电极产生的消融带破坏了睫状体的房水组织,进而减少睫状体内房水的生成,达到降低眼内压、治疗青光眼的目的。对于浅前房眼,经过消融电极消融后,可造成睫状体收缩,增加晶状体与睫状体之间的间隙,减少睫状体阻滞,降低跨晶状体压力差,加深前房。
图1是根据本发明一种用于治疗青光眼的消融电极的整体示意图;
图2是根据本发明一种用于治疗青光眼的消融电极的分解示意图;
图3是根据本发明一种用于治疗青光眼的消融电极的部分剖面示意图;
图4是根据本发明一种用于治疗青光眼的消融电极的定位刻度线示意图;
图5是根据本发明一种用于治疗青光眼的消融主机的第一个实施例示意图;
图6是根据本发明一种用于治疗青光眼的消融主机的第二个实施例示意图;
图7是根据本发明一种用于治疗青光眼的消融主机的第三个实施例示意图。
为了便于理解本发明,下面结合附图和具体实施例,对本发明进行更详细的说明。附图中给出了本发明的较佳的实施例。但是,本发明可以以许多不同的形式来实现,并不限于本说明书所描述的实施例。相反地,提供这些实施例的目的是使对本发明的公开内容的理解更加透彻全面。
需要说明的是,除非另有定义,本说明书所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是用于限制本发明。本说明书所使用的术语“和/或”包括一个或多个相关的所列项目的任意的和所有的组合。
如图1至图3所示,用于治疗青光眼的消融电极1包括位于消融电极中心的中心轴电极2、套设在中心轴电极2***的绝缘套3以及
套设在绝缘套3***的外套电极4。消融电极1整体呈柱状,中心轴电极2、绝缘套3、外套电极4同轴,即中心轴电极2、绝缘套3、外套电极4的中心轴线重合。消融电极1通电后,中心轴电极2与外套电极3之间产生消融带5,消融带5用于作用于睫状体,减少房水的产生。对于浅前房眼,经过消融电极消融后,可造成睫状体收缩,增加晶状体与睫状体之间的间隙,减少睫状体阻滞,降低跨晶状体压力差,加深前房。
本发明中的消融电极1可以轻松进入狭小的眼部空间内对睫状体进行消融,产生可控的微小消融面积;消融带5集中在中心轴电极2与外套电极3之间,消融电极1刺入的位置决定了消融位置,消融位置可是组织表面,也可以是组织内部特定位置。
本发明中的消融电极1为单针消融电极,相对于现有的消融电极尺寸较小,并且在手术时,单针消融电极比现有中的多针消融电极造成的创伤更小,操作人员使用更加精准和便捷。
进一步的,中心轴电极2具有很好的生物相容性,良好的导电性能。中心轴电极2的材质可以是不锈钢,例如2Cr13、1Cr13、1Cr18Ni9、SUS304(L)、SUS316(L)、SUS430等;也可以是钛合金,如TC4等;还可以是纯钛、钨钢、纯钨、铂金、铂铱合金等金属导电材料。
中心轴电极2整体呈圆柱状,中心轴电极2的长度为3mm~50mm,直径为0.1mm~1mm。
优选的,为了方便刺入组织,中心轴电极2的前端被加工为第一锥形尖端21。
进一步的,绝缘套3整体呈圆柱状套管,绝缘套3具有良好的生物相容性和绝缘性,绝缘套3的材质可以是Pary l ene/硅胶/PTFE/ABS/PI。
优选的,绝缘套3的前端被加工为第二锥形尖端31,第二锥形尖端31的头部承接第一锥形尖端21的尾部,即第二锥形尖端31的头部自第一锥形尖端21的尾部向后平滑过渡至第二锥形尖端31的尾部;其锥度与第一锥形尖端21的锥度保持一致。
进一步的,外套电极4具有很好的生物相容性,良好的导电性能。外套电极4的材质可以是不锈钢,例如2Cr13、1Cr13、1Cr18Ni9、SUS304(L)、SUS316(L)、SUS430等;也可以是钛合金,如TC4等;还可以是纯钛、钨钢、纯钨、铂金、铂铱合金等金属导电材料。
外套电极4的长度为3mm~50mm,其内径为0.1mm~1.1mm,外径为0.2mm~1.5mm。
外套电极4的前端被加工为第三锥形尖端41,第三锥形尖端41的头部承接第二锥形尖端31的尾部,即第三锥形尖端41的头部自第二锥形尖端31的尾部向后平滑过渡至第三锥形尖端41的尾部;其锥度与第二锥形尖端31的锥度保持一致,也就是与第一锥形尖端21的锥度保持一致。
进一步的,如图4所示,消融电极1的表面上设置有定位刻度线。定位刻度线做在消融电极1的表面,作为消融电极1刺入深度标尺,方便医生把控刺入深度。定位刻度线可以是环绕消融电极1一周的闭环环线,也可以是半环线或弧线。
优选的,定位刻度线可以通过显示特征标识该显示特征至消融电极1尖端的距离,显示特征可以是颜色,数字,花纹,线宽等。例如在图4中,定位刻度线包括第一显示刻度线101、第二显示刻度线102以及第三显示刻度线103,当然也可以包括更多的显示刻度线,并不局限这三条显示刻度线。
第一显示刻度线101距离消融电极1尖端的长度为L1,第二显示刻度线102距离消融电极1尖端的长度为L2,第三显示刻度线103距离消融电极1尖端的长度为L3。通过这些显示刻度线方便医生把控刺入深度。
进一步的,本发明还提供一种用于治疗青光眼的消融主机,包括如上述的消融电极1,以及连接消融电极1的手柄6,消融电极1与手柄6既可以是可拆卸连接也可以是固定连接,手柄9的尾部通过尾线7连接通电插接件8。
该消融主机的使用过程为:通电插接件8连接电源后消融主机通
电,消融主机将消融能量通过手柄6传输至消融电极1上。消融电极从眼球外部刺入,经巩膜刺入睫状体内,消融主机输出射频消融能量传递到中心轴电极2,能量电流经睫状体组织返回外套电极4。消融效应主要集中在中心轴电极2的尖端,即第一锥形尖端21。在睫状体内,消融电极1产生的消融带5破坏了睫状体的房水组织,进而减少睫状体内房水的生成,达到降低眼内压、治疗青光眼的目的。该方式对开角型青光眼和闭角型青光眼有同等效果。
消融电极使用前需要进行灭菌,灭菌方式有:气体灭菌(环氧乙烷、甲醛、臭氧)、辐射灭菌(微波、紫外线(UV)、X射线和γ射线等)。
优选的,作为消融主机的第一个实施例,如图5所示,手柄6与消融电极1之间为固定连接,手柄6、尾线、通电插接件8为一体结构。
优选的,作为消融主机的第二个实施例,如图6所示,手柄6内部设置有用于识别消融电极1型号的PCB电路板9。消融电极1与手柄6之间为可拆卸连接,消融电极1固定在手柄6上后,PCB电路板9用于对消融电极1的型号进行智能识别,消融主机自动配置相应消融电极1的型号参数,辅助医生操作,缩短手术时间。同时也能对消融电极1的寿命的智能识别,防止过期的消融电极1应用于手术中。
优选的,作为消融主机的第三个实施例,如图7所示,手柄6包括固定连接消融电极1的手柄头部61,即一个消融电极1对应一个手柄头部61;手柄6还包括连接尾线和通电插接件的手柄尾部62,手柄头部61与手柄尾部62之间通过插接的方式连接,即同一个手柄尾部62可以通过插接的方式连接不同类型的手柄头部61,这样能够方便在手术中更换不同型号的消融电极1。
手柄头部61内设置有用于识别消融电极1型号的PCB电路板9,PCB电路板9能够识别该手柄头部61内的消融电极1型号,并将该信息存储,辅助医生操作,缩短手术时间。同时也能对消融电极1的寿命的智能识别,防止过期的消融电极1应用于手术中。
由此可见,本发明公开了一种用于治疗青光眼的消融电极,包括位于消融电极中心的中心轴电极、套设在中心轴电极***的绝缘套以及套设在绝缘套***的外套电极;消融电极整体呈柱状,中心轴电极、绝缘套、外套电极同轴,消融电极通电后,中心轴电极与外套电极之间产生消融带,消融带用于作用于睫状体,减少房水的产生。本发明还提供一种用于治疗青光眼的消融主机,消融主机将消融能量传输至消融电极,消融电极经巩膜刺入睫状体内,消融主机输出射频消融能量传递到中心轴电极,能量电流经睫状体组织返回外套电极。消融电极产生的消融带破坏了睫状体的房水组织,进而减少睫状体内房水的生成,达到降低眼内压、治疗青光眼的目的。对于浅前房眼,经过消融电极消融后,可造成睫状体收缩,增加晶状体与睫状体之间的间隙,减少睫状体阻滞,降低跨晶状体压力差,加深前房。
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书及附图内容所作的等效结构变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。
Claims (10)
- 一种用于治疗青光眼的消融电极,其特征在于:包括位于消融电极中心的中心轴电极、套设在所述中心轴电极***的绝缘套以及套设在所述绝缘套***的外套电极;消融电极整体呈柱状,所述中心轴电极、绝缘套、外套电极同轴,所述消融电极通电后,所述中心轴电极与所述外套电极之间产生消融带,所述消融带用于作用于睫状体,减少房水的产生。
- 根据权利要求1所述的用于治疗青光眼的消融电极,其特征在于:所述中心轴电极的前端被加工为第一锥形尖端。
- 根据权利要求2所述的用于治疗青光眼的消融电极,其特征在于:所述绝缘套的前端被加工为第二锥形尖端,所述第二锥形尖端的头部承接所述第一锥形尖端的尾部。
- 根据权利要求3所述的用于治疗青光眼的消融电极,其特征在于:所述外套电极的前端被加工为第三锥形尖端,所述第三锥形尖端的头部承接所述第二锥形尖端的尾部。
- 根据权利要求1所述的用于治疗青光眼的消融电极,其特征在于:所述中心轴电极的长度为3mm~50mm,直径为0.1mm~1mm。
- 根据权利要求5所述的用于治疗青光眼的消融电极,其特征在于:所述外套电极的长度为3mm~50mm,其内径为0.1mm~1.1mm,外径为0.2mm~1.5mm。
- 根据权利要求1所述的用于治疗青光眼的消融电极,其特征在于:所述消融电极的表面上设置有定位刻度线。
- 一种用于治疗青光眼的消融主机,其特征在于:包括如权利要求1至7任意一项所述的消融电极,以及连接所述消融电极的手柄,所述手柄的尾部通过尾线连接通电插接件。
- 根据权利要求8所述的用于治疗青光眼的消融主机,其特征在于:所述手柄包括固定所述消融电极的手柄头部,以及连接所述尾线和通电插接件的手柄尾部,所述手柄头部与所述手柄尾部之间通过插 接的方式连接。
- 根据权利要求8或9所述的用于治疗青光眼的消融主机,其特征在于:所述手柄内部设置有用于识别所述消融电极型号的PCB电路板。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202221205504.3 | 2022-05-19 | ||
CN202221205504.3U CN217908152U (zh) | 2022-05-19 | 2022-05-19 | 一种用于治疗青光眼的消融电极及消融主机 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023221560A1 true WO2023221560A1 (zh) | 2023-11-23 |
Family
ID=84177857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/074464 WO2023221560A1 (zh) | 2022-05-19 | 2023-02-03 | 一种用于治疗青光眼的消融电极及消融主机 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN217908152U (zh) |
WO (1) | WO2023221560A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN217908152U (zh) * | 2022-05-19 | 2022-11-29 | 苏州朗目医疗科技有限公司 | 一种用于治疗青光眼的消融电极及消融主机 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060111706A1 (en) * | 2001-10-22 | 2006-05-25 | Surgrx, Inc. | Electrosurgical working end for controlled energy delivery |
CN104173105A (zh) * | 2014-09-18 | 2014-12-03 | 安隽医疗科技(南京)有限公司 | 一种新型消融双极针 |
US20160066984A1 (en) * | 2004-06-17 | 2016-03-10 | Serene Medical, Inc. | Ablation apparatus and system to limit nerve conduction |
CN107320177A (zh) * | 2016-04-29 | 2017-11-07 | 周星 | 具有局部浸润麻醉功能的射频消融电极及*** |
CN108013931A (zh) * | 2018-01-04 | 2018-05-11 | 成都美创医疗科技股份有限公司 | 一种低温等离子体手术电极 |
CN111643176A (zh) * | 2020-04-14 | 2020-09-11 | 珠海市司迈科技有限公司 | 一种用于中耳炎微创手术的射频消融电极及其使用方法 |
CN217908152U (zh) * | 2022-05-19 | 2022-11-29 | 苏州朗目医疗科技有限公司 | 一种用于治疗青光眼的消融电极及消融主机 |
-
2022
- 2022-05-19 CN CN202221205504.3U patent/CN217908152U/zh active Active
-
2023
- 2023-02-03 WO PCT/CN2023/074464 patent/WO2023221560A1/zh unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060111706A1 (en) * | 2001-10-22 | 2006-05-25 | Surgrx, Inc. | Electrosurgical working end for controlled energy delivery |
US20160066984A1 (en) * | 2004-06-17 | 2016-03-10 | Serene Medical, Inc. | Ablation apparatus and system to limit nerve conduction |
CN104173105A (zh) * | 2014-09-18 | 2014-12-03 | 安隽医疗科技(南京)有限公司 | 一种新型消融双极针 |
CN107320177A (zh) * | 2016-04-29 | 2017-11-07 | 周星 | 具有局部浸润麻醉功能的射频消融电极及*** |
CN108013931A (zh) * | 2018-01-04 | 2018-05-11 | 成都美创医疗科技股份有限公司 | 一种低温等离子体手术电极 |
CN111643176A (zh) * | 2020-04-14 | 2020-09-11 | 珠海市司迈科技有限公司 | 一种用于中耳炎微创手术的射频消融电极及其使用方法 |
CN217908152U (zh) * | 2022-05-19 | 2022-11-29 | 苏州朗目医疗科技有限公司 | 一种用于治疗青光眼的消融电极及消融主机 |
Also Published As
Publication number | Publication date |
---|---|
CN217908152U (zh) | 2022-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5695495A (en) | Electrosurgical electrode for sclerotherapy | |
CA2723038C (en) | Catheter with helical electrode | |
US7357799B2 (en) | Thermal coagulation using hyperconductive fluids | |
US5755716A (en) | Method for using an electrosurgical electrode for treating glaucoma | |
WO2023221560A1 (zh) | 一种用于治疗青光眼的消融电极及消融主机 | |
US5683386A (en) | Electrosurgical electrode for nail spicule removal procedure | |
CN106974722A (zh) | 具有穿孔端部的导管 | |
CN107019553B (zh) | 温度受控的短持续时间消融 | |
WO2022165962A1 (zh) | 一种球囊电极导管 | |
JPH09504447A (ja) | 熱手段による視力の変更 | |
US6293944B1 (en) | Combined syringe and electrosurgical electrode for sclerotherapy | |
US20220008124A1 (en) | Two-in-one catheter for real-time ultrasound monitoring and radiofrequency ablation | |
CN105997234B (zh) | 用于支气管镜下治疗肺癌的磁导航射频消融导管 | |
EP1296605B1 (en) | Device for myocardial revascularization | |
CN116785011A (zh) | 一种应用于口腔手术的等离子电极 | |
JP2012105766A (ja) | 医療用術具 | |
US20230132044A1 (en) | Galvanic Electrolysis Unit for Hair Follicle Ablation | |
WO2022214953A1 (en) | Ent instrument with rf electrodes on wire frame | |
CN205672073U (zh) | 用于支气管镜下治疗肺癌的磁导航射频消融导管 | |
CN101879060B (zh) | 具有可靠头电极连接的电生理导管 | |
CN214549588U (zh) | 射频等离子消融手术电极 | |
CN110623726B (zh) | 一种射频等离子体刀电极汽化、热凝、切割手术消炎装置 | |
CN204636488U (zh) | 多功能***手术镜剜除切割器 | |
CN220069843U (zh) | 一种带温控控制功能的一次性手术电极 | |
CN217408951U (zh) | 一种用于消融过程中测压力和温度的微型探针 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23806522 Country of ref document: EP Kind code of ref document: A1 |